Stand Down VI: Dow 10,000? It Could Happen.

WILL FALLING RATES SAVE THE DAY? And yet, we're not worried. While we're not predicting it,...
Aphex Biocleanse, Superbug Stock Review

Oh, No. Alcohol-Based Sanitizers Losing Effectiveness Against Superbugs.

Hospital hand sanitizers not potent enough for superbug (Science) Bacterial superbugs are becoming increasingly tolerant of alcohol, the...

Our Favorite Incubator, Incubates! Telehealth in its Future?

True Nature|Mitesco has found an excellent first Company to incubate and help grow, called MyCare.The founders of the Minute Clinic are teaming...

VirnetX (VHC) Scores $440 Million and Citius Pharma (CTXR) Sees Market Expand to Over...

Internet Stock Review Blast from the past scores big! We added VirnetX (VHC)...
biotech stock review ATXI

Avenue Therapeutics (ATXI) Announces New Drug Application for IV Tramadol Accepted for Review by...

IV tramadol for the management of moderate to moderately severe pain in adults in a medically supervised health care setting.

Fortress Bio (FBIO) Inches Closer to $3.00 on Major News.

Fortress Bio (FBIO) Inches Closer to $3.00 on Major News. Citius Pharma (CTXR) Inches Closer to the Next Phase...
Citius, Biotech Stock Review

Citius (CTXR) Achieves 50% Patient Enrollment in Phase 3 Mino-Lok® Pivotal Trial

PHASE III PROGRESS October 7th, 2019, Citius Completes 40% - Triggers Data Being Analyzed (is it working?).December 19th, 2019...

Okay, so What’s Next for Citius Pharma (CTXR) $1.16?

Dawson James Broker/Dealer Updates. Price Target Remains at $7.00. "OK, So what’s Next? Topline data from the superior efficacy...

Latest article

Bavarian Nordic (BVNRY) Freeze Dries its MPOX Vaccine!

This is Big News, Honestly. We Are Adding to 2025 Watch List @ $7.36. We last added Bavarian to...

Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.’s ‘Misinformation And Lies’ (IBD)

Sorting Through the Wreckage! Full post on Investor's Business Daily. Biotech stocks took a beating Monday...

Zomedica (ZOMDF) Surges 40% Higher, Friday.

Stock Surges 40%, After Management Conference Call to Calm the Natives. Insider Buying Unleashed Today? Not...